reported kidney disease, cardiovascular disease or diabetes were investigated. Three eGFR equations based on creatinine and/or cystatin C from the Chronic Kidney Disease Epidemiology Collaboration were studied. Differences between eGFR and mGFR were analyzed with seemingly unrelated regression methods. Results: mGFR in the lowest quartile was associated with an increased multivariable-adjusted odds ratio of retinopathy (OR 1.86, 95% CI 1.16-2.97), but not with retinal artery or vein diameters. eGFR based on cystatin C (eGFR cys ) was consistently biased relative to mGFR in its associations with retinal vessel diameters across different models. eGFR based on creatinine (eGFR crea ) and eGFR based on both creatinine and cystatin C were also biased in several of these models (p < 0.05). For retinopathy, the differences between the 3 eGFR and mGFR measurements were not statistically significant. Conclusions: Low mGFR is associated with retinopathy in the general population. eGFR based on creatinine and/or cystatin C are not valid substitutes for mGFR in studies of the relationship between the retina and kidney function in healthy persons. Few studies have investigated this issue in direct comparison with measured GFR (mGFR). We compared the associations between eGFR and mGFR and retinal vasculopathy, a marker of systemic microvasculopathy. Methods: Iohexol clearance and retinal photography were examined in the Renal Iohexol Clearance Survey in Tromsø 6, which consists of a representative sample of middle-aged persons from the general population. A total of 1,553 persons without self-
reported kidney disease, cardiovascular disease or diabetes were investigated. Three eGFR equations based on creatinine and/or cystatin C from the Chronic Kidney Disease Epidemiology Collaboration were studied. Differences between eGFR and mGFR were analyzed with seemingly unrelated regression methods. Results: mGFR in the lowest quartile was associated with an increased multivariable-adjusted odds ratio of retinopathy (OR 1.86, 95% CI 1.16-2.97), but not with retinal artery or vein diameters. eGFR based on cystatin C (eGFR cys ) was consistently biased relative to mGFR in its associations with retinal vessel diameters across different models. eGFR based on creatinine (eGFR crea ) and eGFR based on both creatinine and cystatin C were also biased in several of these models (p < 0.05). For retinopathy, the differences between the 3 eGFR and mGFR measurements were not statistically significant. Conclusions: Low mGFR is associated with retinopathy in the general population. eGFR based on creatinine and/or cystatin C are not valid substitutes for mGFR in studies of the relationship between the retina and kidney function in healthy persons.
Introduction
The glomerular filtration rate (GFR) is difficult and costly to measure accurately in epidemiological research. For this reason, equations have been developed to estimate the GFR using endogenous substances, primarily serum creatinine and cystatin C. These equations have been shown to have acceptable bias and precision relative to the measured GFR (mGFR). Estimated GFR (eGFR) is now being used as proxy for mGFR in most epidemiological studies of kidney function.
Creatinine and cystatin C have been shown to be influenced by non-GFR factors [1] [2] [3] [4] . Accordingly, the difference between mGFR and eGFR is not random measurement error but partly caused by factors that could also be correlated with disease. Estimates of disease risk based on eGFR could be biased even though the eGFR estimates themselves are unbiased. The difference observed between risk estimates associated with eGFR based on creatinine versus cystatin C indicates that this is the case. It has been hypothesized that combining endogenous filtration markers with different non-GFR determinants in the same estimating equation could alleviate this problem.
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation based on both creatinine and cystatin C is to date the best validated estimating equation based on this principle [5] . However, although it has been found to have less bias and better precision than equations based on either substance alone, it is not known whether it is more similar to mGFR in its associations with clinical manifestations. Because the non-GFR determinants of creatinine and cystatin C differ, it is possible that they cancel out and that this equation is less susceptible to such influences.
We examined this issue in relation to the retinal microvasculature. Retinopathy and narrower retinal arteries and wider veins predict the manifestation of cardiovascular disease (CVD) [6, 7] . The vascular beds of the choroid and the glomeruli share several structural similarities, and important physiological mechanisms as the renin-angiotensin-aldosterone system are found both in the eyes and the kidneys [8] . Accordingly, pathogens that affect the retinal microvasculature would also be expected to influence the glomeruli, as can be seen in, for example, diabetes and hypertension [9, 10] . However, studies of the eGFR and retinal microvasculature in the healthy general population have reached different results, which may partly be due to non-GFR influences on creatinine and cystatin C. The Renal Iohexol Clearance Survey in Tromsø 6 (RENIS-T6) has the largest population-based cohort with mGFR measured as iohexol clearance, which is accepted as an accurate method [11] . The cohort, which consists of a representative sample of the middle-aged general population without manifestations of CVD, diabetes or chronic kidney disease (CKD), has also been investigated with retinal photography. The aim of the present investigation was to compare the associations between retinal vasculopathy, mGFR and the CKD-EPI eGFR equations based on creatinine and/or cystatin C [5] .
Methods

Study Population
The RENIS-T6 was an ancillary part of the sixth survey of the Tromsø study, as previously described [12] . Those invited to the sixth survey (October 2007 to December 2008) included a 40% random sample of individuals aged 50-59 years drawn from the population registry and all individuals aged 60-62 years of the population in the municipality of Tromsø in Northern Norway (5,464 total subjects). Of these, 3,564 subjects aged 50-62 years completed the survey. We excluded 739 subjects with self-reported myocardial infarction, angina pectoris, stroke, diabetes mellitus or renal disease. The remaining 2,825 eligible subjects were invited to the RENIS-T6. Of the 2,107 who responded, we excluded 12 due to an allergy to contrast media, iodine or latex; 65 due to other reasons and 48 who did not present for their appointments. A total of 1,982 subjects remained for inclusion, and 1,632 were investigated according to a predefined target. Five participants were excluded due to technical failures in their GFR measurements, leaving 1,627 included participants in the RENIS-T6 cohort ( fig. 1 ). The cohort has been shown to be representative of all 2,825 eligible subjects [13] .
For the present analyses, persons with a urinary albumin-creatinine ratio (ACR) of >1.92 mg/mmol for men or 2.83 mg/mmol for women [14] or diabetes (fasting serum glucose ≥ 7.0 mmol/l and/or hemoglobin A 1C ≥ 6.5%) were excluded [15] .
A health questionnaire was administered. A family history of early myocardial infarction was defined as a first-degree relative with myocardial infarction less than the age of 60 years. Physical exercise was defined as leisure time activity leading to perspiration or breathlessness.
This study was approved by the Norwegian Data Inspectorate and the Regional Committee for Medical and Health Research Ethics of North Norway. Written informed consent was obtained from all individual participants included in the study. All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Retinal Vessel Diameters and Retinopathy
Retinal photography was performed with the Visucam PRO NM (Carl Zeiss Meditec, Jena, Germany) retinal camera. Computer-assisted measurements of the diameters of all vessels coursing through the area of one-half to one disc diameter from the optic disc margin were performed. Of each type, the 6 largest were summarized as the central retinal artery equivalent and the central retinal vein equivalent [16] .
Retinopathy grading was based on 'The International Clinical Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scales' [17] . Microaneurysms, hemorrhages and cotton-wool spots were counted. The grade for the worse eye was used. For the counts of microaneurysms, hemorrhages and soft exudates, the sums of the counts for both eyes were used. The details have been published previously [18] .
Iohexol Clearance
The GFR was measured as the single-sample plasma clearance of iohexol, which has been validated against gold standard methods [11, [19] [20] [21] . The details have been published previously [12] .
Other Measurements
The methods for measurements of conventional and ambulatory blood pressure have been described previously [22] . Fasting serum glucose, triglycerides and low-density and high-density lipoprotein (LDL and HDL, respectively) cholesterol were measured using a Modular model P800 (Roche Diagnostics, GmbH, Mannheim, Germany). Hemoglobin A 1C was measured with a liquid chromatographic method (Variant II instrument, Bio-Rad Laboratories, Hercules, Calif., USA). Three consecutive samples of first-void spot urine were analyzed for albumin and creatinine, as described previously [23] . The median ACR was used in the analyses.
Invited to the Tromsø 6 study and aged 50 to 62 years n = 5,464
Met and completed the main Tromsø 6 study n = 3,564
Invited to RENIS-T6 n = 2,825
Responders n = 2,107
Eligible for inclusion n = 1,982
Investigated in RENIS-T6 according to a predetermined target n = 1,632
The RENIS-T6 cohort n = 1,627
Present study population n = 1,553
Diabetes (n = 33) according to their fasting plasma glucose or HbA1C, macro-or microalbuminuria (n = 44) (3 person had both diabetes and microalbuminuria) n = 74
Technical failure in the iohexol-clearance measurements n = 5
Excluded because of allergy to contrast media, iodine, or latex, or for other reasons.
Includes 48 who withdrew n = 125
Reported a previous myocardial infarction, angina pectoris, stroke, diabetes mellitus, or any renal disease except urinary tract infection n = 739
Fig. 1. Study population derived from the RENIS-T6, which is an ancillary investigation of the sixth Tromsø study.
Creatinine was analyzed on the Hitachi Modular model using an enzymatic method (CREA Plus, Roche Diagnostics, GmbH, Mannheim, Germany). External quality assessment was provided by Labquality, Helsinki, Finland. The analysis at our laboratory was calibrated with serum X in the Nordic Reference Interval Project, which has been validated against isotope dilution mass spectroscopy [24] . The inter-assay coefficient of variation in the study period was 2.3%.
Cystatin C was measured by particle-enhanced turbidimetric immunoassay using reagents from Gentian (Gentian, Moss, Norway) on a Modular E analyzer (Roche Diagnostics, GmbH, Mannheim, Germany). The inter-assay coefficient of variation in the study period was 3.1%. External quality control was provided by Equalis (www.equalis.se). In 2013, 300 randomly selected samples frozen at -80 ° C were re-analyzed with the same assay on a Cobas 8000 (Roche Diagnostics), and the baseline cystatin C values were recalculated to values standardized to the international reference ERM-DA471/IFCC [25] . Details are given in the online supplemental material (for all online suppl. material, see www. karger.com/doi/10.1159/000441092). eGFR based on creatinine (eGFR crea ), on cystatin C (eGFR cys ) and on both (eGFR creacys ) were calculated with equations developed by the CKD-EPI Collaboration (online suppl. table 1) [5] . The performance of these equations in the RENIS-T6 cohort with regard to bias, precision and accuracy has been reported previously [12, 26] .
Statistical Analyses
Continuous variables are presented as the median (interquartile range). Differences across mGFR quartiles were tested with analysis of variance or median, ordinal logistic, logistic or Poisson regression, as appropriate. Tests for unadjusted linear and quadratic trends were performed using linear and squared terms for mGFR in the regressions. Serum triglyceride values were log-transformed.
Adjusted models of the retinal variables were analyzed with multiple linear or logistic regression using mGFR, eGFR crea , eGFR cys or eGFR creacys as the independent variables. Having a retinopathy grade greater than zero was analyzed as a dichotomous dependent variable in multiple logistic regression analyses. The central retinal artery and vein equivalents were analyzed in the same manner as the dependent continuous variables in multiple linear regression analyses.
For each of the dependent variables above, separate multiple linear or logistic regression analyses were performed with mGFR, eGFR crea , eGFR cys or eGFR creacys as independent variables, both divided into equation-specific quartiles and used as continuous variables. In model 1, we adjusted for age, gender, body weight, height, body mass index, antihypertensive medication, lipid-lowering and non-steroidal anti-inflammatory drugs; and in model 2 for the same variables as in model 1 and, in addition, history of first-degree relative with myocardial infarction before 60 years (yes/no), physical exercise (yes/no), daytime ambulatory mean arterial and pulse pressures, number of currently smoked cigarettes, LDL-and HDLcholesterol, the log of fasting triglycerides and high-sensitivity Creactive protein, urinary ACR and fasting glucose. Seemingly unrelated regression methods were used to test differences between the regression coefficients for the mGFR and the 3 eGFR measurements across the different regression models [27] . Body mass index was calculated as body weight divided by the square of height.
Due to logistic problems, retinal examinations were not performed in some patients. Retinal vessel or retinopathy data were missing in 7.9 and 8.4% of the subjects, respectively. In compliance with current recommendations, missing data were imputed using multiple chained imputation in STATA/MP 12.1 (StataCorp LP, Tex., USA, www.stata.com). All statistical tests were performed on 50 imputed data sets using the STATA. The imputation model has been described in detail in a previous publication [28] .
Statistical significance was defined as p value <0.05.
Results
Of the 1,627 subjects in the cohort, those with microor macroalbuminuria (n = 44) or diabetes (n = 33) were excluded. Three persons had both diabetes and microalbuminuria. Accordingly, 74 subjects were excluded, leaving 1,553 for the present investigation ( fig. 1 ).
There were differences across the mGFR quartiles with regard to several characteristics (p < 0.05; table 1 ). These findings have been discussed previously [1, 22, 29] .
In unadjusted analyses, there were no associations between the retinal changes and mGFR quartiles (p ≥ 0.05; table 2 ). Quadratic trends were not statistically significant for any of the retinal variables in table 2 .
In both model 1 (adjusted for age, sex, medication and anthropometric measures) and 2 (fully adjusted), an mGFR in the lowest quartile was associated with an increased OR for retinopathy (p < 0.05; table 3 ). In model 2, the OR for retinopathy was 1.86 (95% CI 1.16-2.97). The corresponding result for eGFR creacys was similar at 1.63, but not statistically significant. The ORs for eGFR crea and eGFR cys were even lower ( table 3 ) . The results when mGFR and eGFR were analyzed as continuous variables were similar ( table 3 ) . There were no statistically significant quadratic trends across the quartiles for mGFR or any of the eGFR. In all possible pairwise comparisons between the linear trend ORs for mGFR and the 3 eGFR measurements, there were no statistically significant differences between the estimates in any of the models (p > 0.05). Seemingly unrelated regression methods were used for these tests.
eGFR cys was associated with both the central retinal artery and vein equivalents in both models 1 and 2 in the multiple linear regression analyses ( table 4 ). Lower eGFR cys was associated both with wider retinal arteries and veins (p < 0.05). eGFR creacys was associated with wider retinal veins in model 1 (p < 0.05), but not in model 2. eGFR crea in the lowest quartile was associated with narrower veins in model 1 (p < 0.05), but not in model 2. There was no statistically significant quadratic trend across the quartiles for mGFR or any of the eGFR. When comparing all possible pairs of linear trend regression coefficients for mGFR and the 3 eGFR measurements in both models in table 4 with seemingly unrelated regression methods, all the differences between mGFR and eGFR cys were statistically significant. Likewise, all the differences between mGFR and eGFR creacys were statistically significant except for retinal arteries in the fully adjusted model. There was no statistically significant difference between any of the estimates for mGFR and eGFR crea in any of the models. When comparing all possible pairs of estimates for eGFR crea , eGFR cys and eGFR creacys , the differences were all statistically significant ( table 4 ) .
In a sensitivity analysis, all the analyses in tables 3 and 4 were repeated after exclusion of all subjects with mGFR, eGFR crea , eGFR cys or eGFR creacys lower than 60 ml/ min/1.73 m 2 . In the multiple logistic regression analyses of retinopathy, the results were similar to the original analyses (online suppl. table 2). In the multiple linear regression analyses of the retinal vessels, the associations between lower eGFR crea and both narrower arteries and veins were now statistically significant in both models 1 and 2 (online suppl. table 3). The association between eGFR cys and wider arteries in the fully adjusted model 2 was no longer statistically significant. When comparing the estimates for mGFR and eGFR crea , the differences were now all statistically significant except for the retinal arteries in model 2 (p = 0.06).
Discussion
We found an association between low mGFR and retinopathy in the general non-diabetic population, whereas there was no association between mGFR and retinal vessel diameters. If we had not measured GFR, but relied on one of the eGFR equations, the results would have been different. In particular, the use of eGFR cys would have given the result that there was no association with retinopathy, but a strong association with wider retinal vessels for lower eGFR cys . Statistical tests of the differences between the estimates of association across the GFR assessments demonstrated that none of the eGFR was consistently similar to mGFR in their associations with retinal vessel diameters. eGFR crea was similar to mGFR in the main analyses, but this result was not stable when persons with low mGFR or eGFR were excluded in a sensitivity analysis. eGFR cys performed worse than eGFR crea or eGFR creacys both in the main and the sensitivity analysis.
There have been several studies of non-GFR determinants of creatinine and cystatin C [1-4] which may explain the differences between mGFR and eGFR in the present study. However, we are not aware of any previous study where associations between pathological conditions and GFR estimates based on both markers have been compared with mGFR.
To our knowledge, there are no previous cross-sectional studies of the relationship between retinal changes and the GFR in healthy persons from the general population. There are divergent results of investigations of the association between renal vessel diameters and CKD defined as eGFR crea <60 ml/min/1.73 m 2 . Whereas some studies have found an association between narrow retinal arteries or wider retinal veins and the odds of having CKD, others have not [30, 31] .
The results of longitudinal studies of retinal vessel diameters as risk factors for incident CKD also differ. The Multi-Ethnic Study of Atherosclerosis found an association between narrower retinal artery caliber and CKD in Caucasians but not in other races [32] . However, this finding was not reproduced in the Beaver Dam CKD study [33] . Both studies used eGFR crea . The Beaver Dam CKD Study also tested a criterion for CKD based on the cystatin C level, which gave the same result as eGFR crea . The present study indicates that there is no association between retinal vessel diameters and mGFR in the general population. The estimates of the 3 eGFR equations were all different from each other, which may partly explain the divergent results of previous studies (p < 0.05; table 4 ).
With regard to retinopathy, previous studies have found a positive relationship with CKD in non-diabetic persons [30, 31, 34, 35] . Our results indicate that the cross-sectional association between reduced GFR and retinopathy extends into the normal GFR range and that it is independent of microalbuminuria ( table 3 ) . This suggests that microvasculopathy may be the cause of the low mGFR of some of the subjects in the lowest quartile. Increasing age is associated with both retinal vascular damage and GFR decline, and mechanisms of aging could possibly be a common cause of both [8] . Although only mGFR was associated with retinopathy (p < 0.05), none Multiple logistic regression analyses of associations between retinopathy and mGFR and eGFR. The RENIS-T6 study Creatinine and cystatin C of the pairwise differences between mGFR and the 3 eGFR measurements were statistically significant when tested with seemingly unrelated regression methods. Retinopathy has been found to be a strong independent predictor of stroke [7] , but the risk for stroke associated with an eGFR crea in the low normal range has been found to be low and not statistically significant [36] . The attenuated ORs for retinopathy for eGFR crea in the present study suggest that eGFR crea may underestimate the risk for stroke relative to mGFR. The attenuated ORs could be due to a low precision of eGFR or to the influence of non-GFR factors.
The different associations with retinal vessel diameters for eGFR crea and eGFR cys were most likely due to the effects of non-GFR factors on cystatin C and creatinine. Although the differences were small, eGFR is typically used in large epidemiological studies where even small confounding effects may be significant. The difference of 8.1 μm between eGFR crea and eGFR cys for the estimate of the central retinal vein diameter in the lowest quartile ( table 4 ) in this study corresponds to a hazard ratio of 1.2 for intracerebral hemorrhage for eGFR cys relative to eGFR crea in the Rotterdam study [6] and to 1.2 for lacunar stroke in the ARIC study [7] .
The most important strength of our study was that it used mGFR measured as iohexol clearance in a large population survey. Because the RENIS-T6 cohort is homogenous with respect to age, ethnicity and comorbidity and because we excluded those with CKD, CVD or diabetes, the effects of non-GFR factors may be less than those in many other studies. This strengthens the conclusion that there are important differences between eGFR and mGFR. Both the creatinine and cystatin C assays were calibrated to international standards, and we were able to adjust our analyses for most important confounders, including fasting glucose and albuminuria.
One limitation of this investigation is that plasma iohexol clearance may slightly underestimate the gold standard urinary inulin clearance [11] . To make GFR measurements in a large population survey possible, we chose to measure iohexol clearance using the single-sample method. Although some studies have found differences between single-and multiple-sample methods [37] , other studies have found the methods similar [21, [38] [39] [40] [41] . It is unlikely that bias or imprecision of the GFR measurements relative to true GFR would be correlated with retinal changes. Accordingly, this would not be expected to influence our analyses, except possibly for an attenuation of estimates by regression dilution bias, which would not alter our conclusions. Another limitation of this investigation was that ethnicity was not investigated, as the RENIS-T6 cohort included only persons of European ancestry. Also, because subjects with self-reported kidney disease were excluded, our results may not generalize to patients with CKD.
We conclude that the association of retinal changes with mGFR and eGFR based on cystatin C and/or creatinine differs even when other risk factors are adjusted for. The use of eGFR in studies of the relationship between the eye and the kidneys will give biased results relative to mGFR and may fail to detect important relationships as well as identifying spurious ones. The magnitude of bias when eGFR is used as a predictor of other outcomes should be assessed in longitudinal studies comparing mGFR and eGFR.
